IndraLab
Statements
reach
"In the case of adding calcium channel blocking activity, this might lead to lowered blood pressure or negative inotropy; thus, the mixture of hERG blocking activity with calcium channel blockade might have to be reserved for those patients who are already administered such drugs (e.g., verapamil), such as patients with concomitant hypertension.hERG blocking drugs could also be made safer by identification of those patients most susceptible to hERG induced TdP and then limiting the drugs to those patients who are predicted to tolerate the drug well."